CNTX - Context Therapeutics acquires phase 1-ready T cell engager CT-95
2024-07-10 09:02:45 ET
More on Context Therapeutics
- Context Therapeutics stock jumps on $100M private placement
- Seeking Alpha’s Quant Rating on Context Therapeutics
- Historical earnings data for Context Therapeutics
- Financial information for Context Therapeutics